|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Healthcare services income | |||||
| Operating expenses | |||||
| Cost of healthcare services | |||||
| Research and development expenses | |||||
| General and administrative fees | |||||
| Total operating expenses | |||||
| (Loss) gain on investments in marketable securities, net | |||||
| Legal and professional fees | |||||
| Other operating income (expenses) | |||||
| Total operating expenses | |||||
| Other (expense) income, net | |||||
| Loss on investments in marketable securities, net | |||||
| Unrealized gain from fair value change of the long-term investments, net | |||||
| Impairment loss of long-term investment | |||||
| Interest expense, net | |||||
| Gain on disposal of subsidiaries | |||||
| Issuance cost allocated to warrant liability | |||||
| Change in fair value of warrant liability | |||||
| Government subsidies | |||||
| Sundry income | |||||
| Total other income (expense), net | |||||
| Net loss | |||||
| Other comprehensive (loss) income | |||||
| Exchange differences on translation of foreign operations | |||||
| Other comprehensive (loss) income | |||||
| Comprehensive loss | |||||
| Comprehensive (loss) income attributable to non-controlling interests | |||||
| Comprehensive loss attributable to the shareholders of Aptorum Group Limited | |||||
| Comprehensive (loss) income attributable to non-controlling interests | |||||
| Net income (loss) attributable to non-controlling interests | |||||
| Net loss attributable to Aptorum Group Limited | |||||
| Net loss per share attributable to Aptorum Group Limited | |||||
| – Basic (in Dollars per share) | |||||
| – Diluted (in Dollars per share) | |||||
| Weighted-average shares outstanding | |||||
| – Basic (in Shares) | |||||
| – Diluted (in Shares) | |||||
Loading...